NRIX
Nurix Therapeutics Inc
NASDAQ: NRIX · HEALTHCARE · BIOTECHNOLOGY
$16.61
-2.75% today
Updated 2026-04-29
Market cap
$1.72B
P/E ratio
—
P/S ratio
23.93x
EPS (TTM)
$-3.17
Dividend yield
—
52W range
$8 – $23
Volume
1.1M
Nurix Therapeutics Inc (NRIX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.45M | $31.11M | $17.82M | $29.75M | $38.63M | $76.99M | $54.55M | $83.98M |
| Revenue growth (YoY) | — | -16.9% | -42.7% | +66.9% | +29.8% | +99.3% | -29.1% | +54.0% |
| Cost of revenue | $40.51M | $45.02M | $66.49M | $6.08M | $10.81M | $189.15M | $221.63M | $18.86M |
| Gross profit | $-3.06M | $-13.91M | $17.82M | $29.75M | $38.63M | $-112.16M | $-167.08M | $65.12M |
| Gross margin | -8.2% | -44.7% | 100.0% | 100.0% | 100.0% | -145.7% | -306.3% | 77.5% |
| R&D | $40.51M | $45.02M | $66.49M | $116.43M | $184.50M | $189.15M | $221.63M | $308.16M |
| SG&A | $6.67M | $8.33M | $16.31M | $31.20M | $38.00M | $42.90M | $45.94M | $52.74M |
| Operating income | $-9.74M | $-22.24M | $-64.98M | $-117.89M | $-183.87M | $-155.06M | $-213.03M | $-285.67M |
| Operating margin | -26.0% | -71.5% | -364.7% | -396.3% | -476.0% | -201.4% | -390.5% | -340.2% |
| EBITDA | $-6.75M | $-19.88M | $-62.80M | $-111.80M | $-173.06M | $-148.93M | $-205.01M | $-244.84M |
| EBITDA margin | -18.0% | -63.9% | -352.4% | -375.8% | -448.0% | -193.4% | -375.8% | -291.5% |
| EBIT | $-9.74M | $-22.24M | $-64.98M | $-117.89M | $-183.87M | $-155.06M | $-213.03M | $-263.70M |
| Interest expense | $818000.00 | $776000.00 | $3.39M | $6.91M | $14.31M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-9.43M | $-21.70M | $-43.24M | $-117.19M | $-166.04M | $-143.95M | $-193.57M | $-264.46M |
| Net income growth (YoY) | — | -130.2% | -99.3% | -171.0% | -41.7% | +13.3% | -34.5% | -36.6% |
| Profit margin | -25.2% | -69.7% | -242.7% | -393.9% | -429.9% | -187.0% | -354.9% | -314.9% |